These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10891918)

  • 1. Response of leptomeningeal metastases from breast cancer to hormonal therapy.
    Boogerd W; Dorresteijn LD; van Der Sande JJ; de Gast GC; Bruning PF
    Neurology; 2000 Jul; 55(1):117-9. PubMed ID: 10891918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection.
    Ozdogan M; Samur M; Bozcuk HS; Sagtas E; Yildiz M; Artac M; Savas B
    Jpn J Clin Oncol; 2003 May; 33(5):229-31. PubMed ID: 12865466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of leptomeningeal metastases from breast cancer to hormonal therapy.
    Chamberlain MC
    Neurology; 2001 Feb; 56(3):425-6. PubMed ID: 11171923
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine Therapy for Leptomeningeal Metastases from ER-Positive Breast Cancer: Case Report and a Review of the Literature.
    Zoghi B; Elledge R
    Breast J; 2016; 22(2):218-23. PubMed ID: 26748605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated loss of hormonal receptors in leptomeningeal metastasis from estrogen receptor- and progesterone receptor-positive lobular breast cancer.
    Grewal J; Zhou H; Factor R; Kesari S
    J Clin Oncol; 2010 May; 28(13):e200-2. PubMed ID: 20124173
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
    Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC
    Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
    Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
    Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.
    Di Vita M; Zanghì A; Lanzafame S; Cavallaro A; Piccolo G; Berretta M; Grosso G; Cappellani A
    Clin Ter; 2011; 162(5):451-6. PubMed ID: 22041804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.
    Santa-Maria CA; Cimino-Mathews A; Moseley KF; Wolff AC; Blakeley JO; Connolly RM
    Clin Breast Cancer; 2012 Dec; 12(6):445-9. PubMed ID: 23010203
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of locoregional radiotherapy in patients with metastatic breast cancer.
    Mauro GP; de Andrade Carvalho H; Stuart SR; Mano MS; Marta GN
    Breast; 2016 Aug; 28():73-8. PubMed ID: 27240169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
    Jaeckle KA; Dixon JG; Anderson SK; Moreno-Aspitia A; Colon-Otero G; Hebenstreit K; Patel TA; Reddy SL; Perez EA
    Cancer Med; 2020 Nov; 9(21):7935-7942. PubMed ID: 32885617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy.
    Chamberlain MC; Kormanik P
    Arch Neurol; 1998 Apr; 55(4):506-12. PubMed ID: 9561978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.
    Boogerd W; van den Bent MJ; Koehler PJ; Heimans JJ; van der Sande JJ; Aaronson NK; Hart AA; Benraadt J; Vecht ChJ
    Eur J Cancer; 2004 Dec; 40(18):2726-33. PubMed ID: 15571954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital metastasis as the initial presentation in bilateral lobular invasive carcinoma of the breast.
    Saffra N; Rakhamimov A; Wrzolek MA; Solomon WB; Cooper J; Borgen P
    Ophthalmic Plast Reconstr Surg; 2014; 30(2):e30-2. PubMed ID: 23645354
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skull bone metastasis with adjacent leptomeningeal involvement from pleomorphic lobular carcinoma of the breast.
    Chen LY; Ni YB; Lacambra MD; Lee WC; Ho KK; Tse GM
    Histopathology; 2015 Jun; 66(7):1051-3. PubMed ID: 25298018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thyroid metastasis of lobular breast carcinoma].
    Egaña N; Socias C; Matteucci T; Bilbao I; Alvarez-Coca M
    Endocrinol Nutr; 2012 Mar; 59(3):219-20. PubMed ID: 22138624
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
    Chen TW; Jan IS; Chang DY; Lin CH; Chen IC; Chen HM; Cheng AL; Lu YS
    J Neurooncol; 2020 May; 148(1):165-172. PubMed ID: 32346837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
    Waki F; Ando M; Takashima A; Yonemori K; Nokihara H; Miyake M; Tateishi U; Tsuta K; Shimada Y; Fujiwara Y; Tamura T
    J Neurooncol; 2009 Jun; 93(2):205-12. PubMed ID: 19043775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.